Sulfation of selected mono‐hydroxyflavones by sulfotransferases in vitro: a species and gender comparison

Objectives  Sulfation via sulfotransferases is an important metabolic pathway contributing to the low bioavailability of flavonoids. This study aims to characterize the sulfation of mono‐hydroxyflavones (MHFs) to obtain useful information on structure‐metabolizing relationships in animal species and gender differences.

[1]  Paul E Milbury,et al.  Flavonols, flavones, flavanones, and human health: epidemiological evidence. , 2005, Journal of medicinal food.

[2]  J. Goldstein,et al.  Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[3]  Nirmala Raghavan,et al.  Sulfation of O-Demethyl Apixaban: Enzyme Identification and Species Comparison , 2009, Drug Metabolism and Disposition.

[4]  I. Hidalgo,et al.  Inter-species comparison of 7-hydroxycoumarin glucuronidation and sulfation in liver S9 fractions , 2006, In Vitro Cellular & Developmental Biology - Animal.

[5]  Liang Liu,et al.  Mechanisms Responsible for Poor Oral Bioavailability of Paeoniflorin: Role of Intestinal Disposition and Interactions with Sinomenine , 2006, Pharmaceutical Research.

[6]  T. Walle,et al.  Glucuronidation versus oxidation of the flavonoid galangin by human liver microsomes and hepatocytes. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[7]  S. Ekman,et al.  Metabolism of human cytochrome P450 marker substrates in mouse: a strain and gender comparison , 2004, Xenobiotica; the fate of foreign compounds in biological systems.

[8]  Juan-Pablo Hernández,et al.  Gender-specific induction of cytochrome P450s in nonylphenol-treated FVB/NJ mice. , 2006, Toxicology and applied pharmacology.

[9]  T. Zhou,et al.  Sulfation of dietary flavonoids by human sulfotransferases , 2009, Xenobiotica; the fate of foreign compounds in biological systems.

[10]  I. Hidalgo,et al.  Glucuronidation and sulfation of 7-hydroxycoumarin in liver matrices from human, dog, monkey, rat, and mouse , 2005, In Vitro Cellular & Developmental Biology - Animal.

[11]  C. Klaassen,et al.  Mechanisms of gender-specific regulation of mouse sulfotransferases (Sults) , 2011, Xenobiotica; the fate of foreign compounds in biological systems.

[12]  Wei Liu,et al.  Use of Isoform-Specific UGT Metabolism to Determine and Describe Rates and Profiles of Glucuronidation of Wogonin and Oroxylin A by Human Liver and Intestinal Microsomes , 2010, Pharmaceutical Research.

[13]  E. Tanaka.  Gender‐related differences in pharmacokinetics and their clinical significance , 1999, Journal of clinical pharmacy and therapeutics.

[14]  Ming Hu,et al.  Commentary: bioavailability of flavonoids and polyphenols: call to arms. , 2007, Molecular pharmaceutics.

[15]  R. Singh,et al.  Structure and concentration changes affect characterization of UGT isoform-specific metabolism of isoflavones. , 2009, Molecular pharmaceutics.

[16]  R. Singh,et al.  Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes. , 2010, Molecular pharmaceutics.

[17]  Huimin Lin,et al.  Disposition Mechanisms of Raloxifene in the Human Intestinal Caco-2 Model , 2004, Journal of Pharmacology and Experimental Therapeutics.

[18]  C. Bouteloup-Demange,et al.  Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice , 2003, European Journal of Clinical Nutrition.

[19]  Benoît Schilter,et al.  Tandem mass spectrometry analysis of N2-(trans-Isoestragol-3'-yl)-2'-deoxyguanosine as a strategy to study species differences in sulfotransferase conversion of the proximate carcinogen 1'-hydroxyestragole. , 2007, Chemical research in toxicology.

[20]  Wei Liu,et al.  Species and Gender Differences Affect the Metabolism of Emodin via Glucuronidation , 2010, The AAPS Journal.